Replies to post #103206 on Biotech Values

[mcbio]

Re: PFE acquiring FoldRx/FOLD

PFE acquires FoldRx for undisclosed sum:

finance.yahoo.com/news/Pfizer-to-Acquire-FoldRx-prnews-1250088574.html?x=0&.v=1

p.s. #msg-8096564 :- )

p.p.s #msg-36998307 is a good background read.

From a macro standpoint, I wonder if this news is bullish for the publically-traded FOLD who also is working in the area of targeting misfolded proteins (and has a candidate in Phase 3; of course, FOLD's partner for the drug, Shire, abandoned the company before the start of Phase 3 trials, which probably isn't a good sign). Perhaps PFE or another big pharma may have some interest in FOLD. Or maybe from a micro standpoint this news is bearish for FOLD because PFE passed it over for FoldRx.